New oral antiviral drug to be used for treatment of COVID-19
By Zhang Zhihao |
chinadaily.com.cn |
Updated: 2023-03-23 19:18
Share
Share - WeChat
The National Medical Products Administration has recently granted conditional market approval for an oral antiviral drug RAY1216 in a bid to treat COVID-19.
The drug can be used to treat adults with mild and moderate symptoms of COVID-19, but it must be taken under medical supervision, the administration said.
RAY1216 is a drug developed by Guangdong Zhongsheng Pharmaceutical.
- China starts construction of water diversion project to quench thirst of metropolis
- China's Greater Bay Area builds world-class city cluster through connectivity, innovation
- Guangzhou forestry and fruit expo to showcase Xinjiang's specialty products
- Xi's special envoy to attend inauguration of Bolivia's president
- Tianjin's Hangu Salt Field marks 1,100th anniversary
- Explainer: What does China's 2035 per capita GDP goal of 'mid-level developed country' status mean
